中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
17期
427-428
,共2页
陈铿%肖光明%张健珍%张春兰
陳鏗%肖光明%張健珍%張春蘭
진갱%초광명%장건진%장춘란
降钙素原%慢加急性肝功能衰竭%预后
降鈣素原%慢加急性肝功能衰竭%預後
강개소원%만가급성간공능쇠갈%예후
Procalcitonin%Acute-on-chronic liver failure%Prognosis
目的探讨慢加急性乙型肝炎肝功能衰竭患者血浆降钙素原(PCT)水平的变化及其临床意义。方法59例慢加急性乙型肝炎肝功能衰竭患者计算MELD评分,根据预后分为存活组26例及死亡组33例,测定血浆降钙素原水平。结果死亡组患者血浆PCT阳性率、血浆PCT水平均高于存活组(P<0.05);MELD评分>30组患者血浆PCT水平高于MELD评分≤30组(P<0.05);患者血浆PCT与MELD评分呈正相关(rp=0.318,P<0.05)。结论慢加急性乙型肝炎肝功能衰竭患者血浆降钙素原水平在评价疾病严重程度及预后判断有一定价值。
目的探討慢加急性乙型肝炎肝功能衰竭患者血漿降鈣素原(PCT)水平的變化及其臨床意義。方法59例慢加急性乙型肝炎肝功能衰竭患者計算MELD評分,根據預後分為存活組26例及死亡組33例,測定血漿降鈣素原水平。結果死亡組患者血漿PCT暘性率、血漿PCT水平均高于存活組(P<0.05);MELD評分>30組患者血漿PCT水平高于MELD評分≤30組(P<0.05);患者血漿PCT與MELD評分呈正相關(rp=0.318,P<0.05)。結論慢加急性乙型肝炎肝功能衰竭患者血漿降鈣素原水平在評價疾病嚴重程度及預後判斷有一定價值。
목적탐토만가급성을형간염간공능쇠갈환자혈장강개소원(PCT)수평적변화급기림상의의。방법59례만가급성을형간염간공능쇠갈환자계산MELD평분,근거예후분위존활조26례급사망조33례,측정혈장강개소원수평。결과사망조환자혈장PCT양성솔、혈장PCT수평균고우존활조(P<0.05);MELD평분>30조환자혈장PCT수평고우MELD평분≤30조(P<0.05);환자혈장PCT여MELD평분정정상관(rp=0.318,P<0.05)。결론만가급성을형간염간공능쇠갈환자혈장강개소원수평재평개질병엄중정도급예후판단유일정개치。
Objective To investigate the changes and the clinical signiifcance of serum procalcitonin (PCT) in patients with acute-on-chronic hepatitis B liver failure. Methods According to the clinical outcome, 59 patients with acute-on-chronic hepatitis B liver failure were divided into survival group (n=26) and death group (n=33). Register the MELD score and measure the levels of serum procalcitonin of the patients. Results Patients in death group had a higher positive rate and a higher value of serum procalcitonin than those in survival group(P<0.05). Patients in MELD score>30 group had a higher value of serum procalcitonin than those in MELD score≤30 group (P<0.05). There was a positive correlation between the value of serum procalcitonin and MELD score (rp=0.318, P<0.05). Conclusions The value of serum procalcitonin may be helpful in predicting the severity of the illness and prognosis in patients with acute-on-chronic hepatitis B liver failure.